-
In the Moment- Fall 2015
Chris Hixon, Lesley K. Glenn, Kristina Giard-Bradford.
-
The Work-Cancer Balance
Some patients want to work through illness and others need to, but juggling work responsibilities and treatment regimens can be a challenge.
by Leigh Labrie
-
The DCIS Dilemma
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Survivor Profile
A Desire to HelpSince P.J. Lukac's glioblastoma diagnosis, the young pediatrician has worked hard to spread awareness and understanding of the disease.
by Stephen Ornes
-
Yesterday & Today
The Voice of Lamb ChopVentriloquist Shari Lewis and her sidekick, a white wool puppet named Lamb Chop, won the hearts of generations of children who tuned in to her television shows.
by Jocelyn Selim
-
The Cost of Cancer
Expensive treatments can leave patients with a mountain of debt. Resources are available to help.
by Bara Vaida
-
In the Moment- Summer 2015
Beverly McKee, Charlie Haygood, Patricia Fernandes.
-
Preserving the Future
Young adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
-
The Ways We Approach Death
Cancer often requires making difficult decisions in the face of uncertainty.
by Sue Rochman
-
Yesterday & Today
Improbable ChampionSusan Butcher won Alaska's grueling Iditarod dog-sled race four times. Her 2005 leukemia diagnosis marked the beginning of her greatest challenge.
by Jocelyn Selim
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore